Cattail

Cattail (Typha spp.): A Comprehensive Reference

1. Identity and Botanical Classification

Taxonomy and Species

Cattail belongs to the genus Typha, the sole genus of the family Typhaceae, which is placed in the order Poales within the monocot clade of flowering plants. According to the APG II system of 2003, the Typhaceae family is assigned to the order Poales in the clade Commelinids, within the monocots, and consists of one genus (Typha), totalling approximately a dozen species of perennial plants of wet habitats.

The medically and nutritionally most significant species include:

• Typha angustifolia L. (narrowleaf cattail) — the species most extensively used in Traditional Chinese Medicine, known in Chinese as Pu Huang (蒲黃). Known as "Pu Huang" in Chinese, it is a botanical drug renowned for its styptic and blood-stasis properties.
• Typha latifolia L. (broadleaf cattail, common cattail) — widely distributed across North America, Europe, and Asia; extensively used by Indigenous North American peoples. It is also known as great reedmace, common cattail, cat-o'-nine-tails, cooper's reed, and cumbungi.
• Typha domingensis Pers. (southern cattail) — common in subtropical and tropical wetlands; used by many Indigenous peoples of the Americas.
• Other species including T. orientalis, T. elephantina, T. capensis, and T. laxmanni have regional medicinal relevance.

T. latifolia shares its range with other related species, and hybridizes with Typha angustifolia (lesser bulrush or narrow-leaf cattail) to form Typha × glauca.

Morphological Description

Typha angustifolia is a perennial plant, typically reaching a height of 1.5–3 m. The rhizomes of the plant are milky yellow in color. The stem is erect and stout in the aboveground portion, gradually tapering as it ascends. Members of the family can be recognized as large marsh herbs with two-ranked leaves and a brownish compact spike of unisexual flowers. The characteristic brown, velvety, sausage-shaped flowering spike is composed of male flowers positioned above and densely packed female flowers below.

Common cattail (Typha latifolia) and narrowleaf cattail (T. angustifolia) are perennial species commonly found in wet or saturated soils in marshes, fens, and other areas; T. latifolia shows lower salt tolerance than T. angustifolia.

Common Names and Synonyms

Cattail is known by an array of vernacular names across cultures: reedmace, bulrush, cat-o'-nine-tails, Cossack asparagus, reed mace, punks, corn dog grass, cumbungi, and raupo (in New Zealand). In Chinese medicine it is exclusively called Pu Huang or Pollen Typhae. The dried pollen preparation is formally referred to in pharmacopoeial contexts as Typhae Pollen or Pollen Typhae.

Plant Parts Used

Multiple parts of the cattail plant have recognized uses:

• Pollen (dried male inflorescence pollen): the primary medicinal part in Chinese medicine and the most studied pharmacologically.
• Rhizomes: used as both food (starch source) and medicine.
• Young shoots and leaf bases: consumed as vegetables.
• Female inflorescence (fluff/down): used topically for wound dressing and hemostasis.
• Leaves: used for weaving and externally as a skin wash.

Leaf bases and rhizome apices of T. angustifolia are edible vegetables, while stems and leaves are utilized for weaving mats and other crafts, as well as in paper manufacturing; the female flower can be employed as filling for pillow cores and cushions.

Common Dosage Forms and Preparations

In Traditional Chinese Medicine, the pollen is prepared and administered in two principal forms:

• Raw pollen (Sheng Pu Huang): used to invigorate blood circulation and resolve blood stasis.
• Charred pollen (Pu Huang Tan): produced by heating raw pollen to charring; used primarily for hemostasis (stopping bleeding). Raw pollen invigorates the Blood; charred (Pú Huáng Tàn), it stops bleeding. Chemical changes of Typha angustifolia in the charring process result in a significant decrease in most flavonoid glycosides and an increase in some flavonoid aglycones (e.g., isorhamnetin, quercetin, and kaempferol); those newly yielded compounds are associated with enhanced hemostatic activity.
• Decoctions: aqueous preparations of the rhizome or pollen.
• Rhizome flour: dried, powdered rhizome incorporated into food preparations.
• Topical application: pollen or inflorescence fluff applied directly to wounds.
• Extracts: standardized ethanolic or aqueous extracts used in modern pharmaceutical formulations.

The yellow male inflorescence, located at the top of cattail flower spikes, is usually collected in summer. After collection, it is dried in the sun, ground, and sifted for fine powder. It is generally used raw or fried.

2. Traditional and Historical Use

Traditional Chinese Medicine

As a botanical drug, Typha angustifolia boasts a medicinal legacy spanning over 1,900 years in China. The first documented record of T. angustifolia appears in the Shen Nong Ben Cao Jing, the earliest Chinese treatise on materia medica, which dates to over 1,900 years ago. It describes T. angustifolia as a Chinese herbal medicine known for its diuretic, analgesic, and hemostatic effects.

In the Tang Dynasty, the herbal book Yao Xing Lun records that T. angustifolia had a prominent hemostatic effect and could be used to treat a variety of bleeding diseases, including abnormal uterine bleeding, nasal mucosal bleeding, and hematuria. In the Song Dynasty classic Ri Hua Zi Ben Cao, it records that T. angustifolia can be used to treat epigastric pain, dysmenorrhea, irregular menstruation, urinary retention, and hematochezia.

Known as "Pu Huang" in Chinese, the species is an herbal drug renowned for its styptic and blood-stasis properties. Traditional Chinese Medicine extensively utilizes T. angustifolia in the treatment of dysmenorrhea, irregular menstruation, abdominal pain, trauma bleeding, soft tissue contusion, hematochezia, hematuria, and functional uterine bleeding.

In TCM theory, the raw pollen acts to invigorate blood and resolve stasis, while the charred form acts as an astringent hemostatic. Studies report procoagulant activity in charred preparations, vasodilation and lipid-lowering effects in raw preparations, and uterine stimulation. Modern Chinese cardiology uses Pú Huáng–Wǔ Líng Zhī formulas for angina pectoris with blood stasis.

Native North American Traditions

Traditionally, common cattail (Typha latifolia) has been a part of many native North American cultures, as a source of food, medicine, and for other uses. Indian peoples in both arid and more moist regions utilized virtually every part of the cattail. The roots provided a source of starch; the leaves were woven into containers. Cattails are prolific pollinators, and the flowers and pollen were consumed and utilized for ceremonial purposes.

Native peoples of the desert also utilized cattail, including the Western Apache, Pima, Papago, Cahuilla, Maricopa, Mohave, Cocopa, Kamia, Paipai, and many others. The seeds, roots, basal stems, and rhizomes provided a source of starch; the leaves provided material for trays and other types of basketry; and the flowers and pollen had symbolic functions in many rituals.

Medicinally, numerous North American nations used cattail for wound care. In Northern America, Typha latifolia fruits have been used for more than 4,000 years for the treatment of skin disorders, burns, and as wound dressing to absorb the ichors. The Waccamaw Siouan used the juice from the stem as an analgesic, similar to aloe. The fluff could also be used as a bandage in wound healing. In Lumbee herbal medicine, the juice between the leaves is used as a skin antiseptic. Other tribes used the roots as a poultice for wound dressing.

Among northeastern tribes, the pollen was used as a hemostatic and astringent, placed directly on cuts to control bleeding, taken internally for internal bleeding, menstrual pain, chest pains, and other forms of blood stagnation, and was also used as a mild diuretic and emmenagogue.

Food uses were highly diverse and well documented. Nearly every part of the plant is edible at some point during the year. The rhizomes can be consumed year-round but are best from fall to early spring; they can be roasted, boiled, grated, ground, or dried and milled into flour. In spring, young shoots emerging from the rhizomes and the tender core of the leaf bundles can be eaten raw or cooked, tasting similar to cucumber. Young flower stalks can be boiled and eaten like corn on the cob. Pollen, which is high in protein, can be mixed with flour and used to make pancakes and baked goods.

Other Ethnobotanical Traditions

In North Africa and the Mediterranean region, Typha species have been used in folk medicine for decoctions against eye diseases, colds, and tonsillitis, and as a sudorific agent. Other folk uses include application in folk veterinary medicine, cicatrizing and antiseptic effects, and the use of decoctions against eye diseases, colds, tonsillitis, and as a sudorific agent, as well as its use in wart healing.

In South Asian traditions, pollen grains have been used for kidney stones, dysmenorrhea, abnormal uterine bleeding, and abscesses. The woolly soft inflorescence is hemostatic and used for dressing ulcers and wound healing. Folkloric uses of the pollen grains of T. angustifolia include kidney stones, dysmenorrhea, abnormal uterine bleeding, abscesses, and also tapeworm infestation, diarrhea, and dysentery.

3. Key Constituents and Active Compounds

Overall Phytochemical Profile

Typha angustifolia contains a rich array of chemical metabolites, with 94 compounds having been isolated and identified thus far. These compounds include flavonoids, steroids, phenylpropanoids, organic acids, volatile oils, and other compounds. Among these, T. angustifolia contains abundant bioactive metabolites, including flavonoids, steroids, alkaloids, organic acids, and volatile oils; flavonoids are considered the most representative active metabolites.

Flavonoids

Flavonoids are the primary pharmacologically active class of compounds in Typha pollen. Flavonoid compounds are abundant in T. angustifolia and are considered the basis of many pharmacological activities such as anti-inflammation, analgesia, and anti-hyperlipidemia.

A total of 16 flavonoids have been isolated and identified from T. angustifolia, including Isorhamnetin, Kaempferol, Quercetin, Naringenin, Quercetin-3-O-rutinose, 3,3′-Dimethylquercetin, Cacticin, Isorhamnetin-3-O-(2G-α-rhamnosyl)-rutioside, Quercetin-3-O-(2G-α-L-rhamnosyl)-rutioside, Isorhamnetin-3-O-neohesperidin, Narcissin, Kaempferol-3-O-neohesperidoside, Quercetin-3-O-neohesperidoside, Picatechin, Catechin, and Typhaneoside.

Two flavonoids of particular pharmacological significance are Typhaneoside and Isorhamnetin-3-O-neohesperidoside (I3ON). Isorhamnetin-3-O-neohesperidin and Typhaneoside have been reported to have significant antioxidant activities and to promote the proliferation of human umbilical vein endothelial cells in vitro.

Sterols and Steroids

Typha rhizomes present a wide variety of chemical compounds, among them saponins, coumarins, and flavonoids. The sterol fraction of the pollen includes β-sitosterol, β-sitosterol glucoside, β-sitosterol palmitate, and stigmasterols. β-sitosterol palmitate can inhibit smooth muscle cell proliferation, and β-sitosterol glucoside showed an inhibitory effect on platelet aggregation in cell-culture studies.

Compounds typhaphthalide, typharin, sitosterol, afzelechin, epiafzelechin, (+)-catechin, and (−)-epicatechin were also isolated and identified from rhizomes of Typha capensis.

Polysaccharides

Water-soluble polysaccharides have been isolated from T. latifolia fruits and characterized structurally. These are among the components that confer wound-healing activity, specifically through keratinocyte-stimulatory mechanisms (see Section 5).

Other Constituents

The pollen of T. angustifolia contains a variety of constituents including flavonoids, stigmasterols, fatty acids, nucleosides, and cerebrosides. Modern studies have found that pollen grains of Typha mainly contain sterols, terpenoids, flavonoid glycosides, cerebrosides, and long-chain hydrocarbons.

4. Established Mechanisms of Action

Hemostatic / Procoagulant Mechanisms

The dual hemostatic action of cattail pollen — whereby the raw form can have both anti-stasis and procoagulant properties depending on processing — has been explored at the molecular level. As early as 1988, Ishida et al. identified two flavonoids in Pollen Typhae that have hemostatic activities after intraperitoneal administration. Zhao et al. (1990) isolated 12 compounds from Pollen Typhae; among them, isorhamnetin-3-O-rhamnosyl-glucoside increased the tissue plasminogen activator (tPA) and prostacyclin levels in aortic endothelial cells. Quercetin-3-O-neohesperidose prevented fibrin-induced endothelial cell injury and increased tPA activity.

Charring of the pollen alters the compound profile in ways that enhance coagulation. Chemical analysis of the charring process of T. angustifolia found a significant decrease in most flavonoid glycosides and an increase in flavonoid aglycones (e.g., isorhamnetin, quercetin, and kaempferol) and newly formed compounds; those compounds are associated with the enhanced hemostatic activity. Components with increasing contents, such as flavonoid aglycones and organic acids, are likely related to the enhancement of hemostasis.

Antiatherogenic and Antiplatelet Mechanisms

Based on previous investigations into pollen Typhae as a Traditional Chinese Medicine with antiatherogenic effects, several components were isolated and their effects on porcine aortic endothelial cells and smooth muscle cell cultures, as well as on platelet aggregation, were examined. Twelve components isolated from Pollen Typhae were identified on their chemical structures and biological effects; four of them showed evident antiatherogenic effects. Specifically, isorhamnetin-3-O-rhamnosyl-glucoside could stimulate endothelial cells to produce tPA and PGI₂; quercetin-3-O-neohesperidose could protect endothelial cells from injury by fibrin; β-sitosterol palmitate could inhibit smooth muscle cell proliferation; and β-sitosterol glucoside showed an inhibitory effect on platelet aggregation.

Antioxidant Mechanisms

Ethanol extracts of T. angustifolia showed IC₅₀ values in DPPH assay of 39.51 ± 0.72 and Fe³⁺ reducing activity of 82.76 ± 13.38, which were higher than those of the water extract (IC₅₀ 50.85 ± 0.74 and 106.33 ± 6.35, respectively). At the cellular level, Typhaneoside and I3ON decreased MDA and NO levels and increased SOD level at a concentration of 70 μmol/L compared with the LPS group.

Anti-inflammatory Mechanisms

Numerous in vitro studies have demonstrated the wide range of biological activities exhibited by flavonoids from T. angustifolia, including anti-inflammatory, analgesic, anti-platelet aggregation, anti-atherosclerosis, and anti-oxidation. In LPS-stimulated endothelial cell models, the constituents from Typha angustifolia could represent a novel therapeutic strategy for LPS-induced inflammation.

Wound-Healing Mechanisms

Research clearly indicates a rationale for the traditional use of Typha latifolia fruit extracts for wound healing; the strong stimulatory activity of the polysaccharides on keratinocyte proliferation and early differentiation are major activities necessary for potent wound-healing agents. T. angustifolia has been used as a traditional Chinese medicine with the abilities to improve microcirculation, inhibit the immune system, induce uterine contractions, treat atherosclerosis and wound healing, as well as induce the differentiation and stimulate the proliferation of human keratinocytes.

5. Scientific Evidence by Area of Use

5.1 Hemostasis and Bleeding Disorders

Traditional use basis: Pollen Typhae (Pu Huang) is the dried pollen of Typha angustifolia. Historically, it has been used broadly to treat hematuria, metrorrhagia, and other diseases due to its blood stasis elimination, hemostatic, and diuretic effects.

Preclinical evidence: Laboratory studies have identified specific compounds responsible for hemostatic activity. Early research in 1988 (Ishida et al.) confirmed flavonoid-based hemostatic activity of compounds isolated from T. latifolia pollen following intraperitoneal administration in animal models. The charred preparation of the pollen has been shown to shorten clotting time and boost fibrinogen levels in preclinical models.

Modern clinical context: T. angustifolia is extensively utilized in modern clinical practice in treating dysmenorrhea, irregular menstruation, trauma bleeding, soft tissue contusion, hematochezia, hematuria, and abnormal uterine bleeding. However, it should be noted that the bulk of evidence supporting these clinical applications originates from Traditional Chinese Medical practice and pharmacological studies rather than large-scale, double-blind, randomized controlled trials. The evidence in a strict Western clinical sense remains preliminary for most specific indications.

Evidence strength: Moderate preclinical (in vitro and animal) evidence; limited formal clinical trial evidence by Western standards. Extended traditional use over 1,900 years provides strong historical context.

5.2 Cardiovascular and Lipid-Lowering Effects

Preclinical evidence: In vitro cell culture studies found antiatherogenic effects of components isolated from Pollen Typhae, providing information for the search of new drugs in the treatment and prevention of atherosclerosis. Multiple isolated compounds were shown to affect endothelial function, platelet aggregation, and smooth muscle cell proliferation — all relevant to atherosclerosis pathophysiology.

Phenolic extracts of T. gallica also displayed antihyperlipidemic activity, decreasing the levels of cholesterol, triglycerides, LDL-C, and VLDL-C while increasing HDL-C levels (animal study).

Modern clinical use: In modern clinical practice, T. angustifolia is utilized in the treatment of benign prostatic hyperplasia, hyperlipidemia, and fundus vascular lesions.

Evidence strength: Preclinical (in vitro, some animal) evidence is supportive. No large randomized controlled clinical trials for these indications have been identified in indexed literature.

5.3 Anti-inflammatory Effects

Animal study: A study was designed to evaluate the anti-inflammatory activity of aqueous and 70% methanolic extracts of pollen grains of Typha angustifolia. Female Sprague Dawley rats were used for the study. The acute anti-inflammatory activity of pollen grains was studied using carrageenan as the phlogistic agent, whereas its chronic anti-inflammatory effect was investigated by percentage inhibition of cotton pellet-induced granuloma. Both aqueous and 70% methanolic extracts showed significant dose-dependent inhibition of carrageenan-induced paw edema as compared to control (P<0.001).

Both extracts at a dose of 125 mg/kg inhibited granuloma formation by 44.30%, which was higher than at doses of 500 or 250 mg/kg, thus causing a significant (P<0.001) non-dose-related inhibition of granuloma formation.

The results of this study indicate that extracts of pollen grains of T. angustifolia are effective in the treatment of both acute and chronic inflammatory conditions and thus support its traditional utilization.

Evidence strength: Animal model studies only; no human clinical trials have been identified. Results are preliminary and cannot be directly extrapolated to clinical use in humans.

5.4 Wound Healing and Skin

In vitro study: In Northern America, T. latifolia fruits have been used for more than 4,000 years for treatment of skin disorders, burns, and as wound dressing. Studies attempted to characterize water-soluble polysaccharides from aqueous Typha latifolia extracts and to investigate the influence of the polymers on cell physiology of human dermal fibroblasts and epidermal keratinocytes.

The results clearly indicate a rationale for the traditional use of Typha latifolia fruit extracts for wound healing due to the strong stimulatory activity of polysaccharides on keratinocyte proliferation and early differentiation — major activities necessary for potent wound-healing agents.

Evidence strength: In vitro data only; no clinical trials have been identified for wound healing in humans using Typha preparations. Evidence supports a plausible mechanism, consistent with long-standing ethnobotanical use, but is not sufficient to establish clinical efficacy.

5.5 Intestinal Anti-inflammatory / Colitis

Animal study: A study published in BMC Complementary and Alternative Medicine (2012) evaluated the preparation of flour from rhizomes of cattail (Typha angustifolia) and its efficacy in TNBS (trinitrobenzenesulphonic acid)-induced rat colitis, including macroscopic, clinical, biochemical, histopathological, and microbiological assessments of its healing effects.

Testing several concentrations of cattail rhizome flour found that dietary supplementation with 10% cattail rhizome flour showed the best effects at reducing the extension of the lesion, the colon weight ratio, adherences to adjacent organs, and diarrhea.

Evidence strength: Single animal (rat) study; no human clinical data. Findings are preliminary.

5.6 Antioxidant Activity

Multiple in vitro studies have confirmed antioxidant capacity of Typha extracts and isolated compounds. Typhaneoside and I3ON promoted cell proliferation at concentrations of 2.8 to 70 μmol/L (p<0.01) and decreased MDA and NO levels while increasing SOD levels in LPS-stimulated human umbilical vein endothelial cells. For T. domingensis, polyphenolic quantification revealed that n-butanol fractions were comparatively rich in total phenolic content (97.14 mg GAE/g) and flavonoid content (362.5 mg QE/g DE).

Evidence strength: In vitro evidence only; no human intervention trials on antioxidant endpoints.

5.7 Analgesic Effects

Research has explored the effect of T. angustifolia on the regulation of pain perception in rats using a pressure plate pain measurement method, finding that the analgesic activity of T. angustifolia was dose-dependent. Flavonoids including isorhamnetin-3-O-neohesperidoside and typhaneoside are proposed as contributors to this activity.

Evidence strength: Animal model data; no published human clinical trials specifically for analgesia using Typha preparations.

5.8 Antimicrobial Activity

Phytochemical evaluation and antimicrobial potency of Typha angustifolia has been investigated against gram-negative bacterial strains including Enterobacter aerogenes, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Escherichia coli (clinical isolates). Pollen grains of Typha have demonstrated antimicrobial activity in in vitro studies.

Evidence strength: In vitro only; no clinical studies.

6. Body Systems and Health Areas Associated with Cattail

• Hematological / Hemostatic system: Primary area of documented use; pollen exerts both procoagulant (charred form) and blood-stasis-resolving (raw form) effects.
• Gynecological and reproductive health: Traditional medicine uses it to treat a variety of bleeding disorders and gynecological diseases. Specific indications include dysmenorrhea, irregular menstruation, postpartum bleeding, and uterine bleeding.
• Urinary tract: Used traditionally for hematuria (blood in urine) and stranguria (difficult, painful urination).
• Cardiovascular system: Components act on endothelial function, platelet aggregation, and smooth muscle cell proliferation; preclinical antiatherosclerotic evidence exists.
• Gastrointestinal system: Rhizome flour has demonstrated intestinal anti-inflammatory effects in rat colitis models; also used traditionally for epigastric pain and diarrhea.
• Dermatological / wound healing: The woolly soft inflorescence is hemostatic and used for dressing ulcers and wound healing. Polysaccharides from fruits stimulate keratinocyte proliferation in vitro.
• Musculoskeletal: Used for soft tissue contusion and trauma-related bleeding in TCM clinical practice.
• Metabolic: Preclinical evidence for cholesterol and triglyceride-lowering effects; used clinically in China for hyperlipidemia.

7. Dosage Forms and Reported Dosages

Dosages described in the scientific literature are primarily from preclinical (animal) studies and TCM clinical practice guidelines. No large-scale human pharmacokinetic dose-finding studies have been identified in peer-reviewed indexed literature.

• Anti-inflammatory (preclinical, rat model): Aqueous and 70% methanolic extracts of T. angustifolia pollen were studied at doses of 125, 250, and 500 mg/kg body weight. At 125 mg/kg, both extracts inhibited granuloma formation by 44.30%, which was higher than the effect seen at 250 and 500 mg/kg doses.
• Intestinal anti-inflammatory (preclinical, rat model): Dietary supplementation with 10% cattail rhizome flour showed the best effects in reducing colitis markers in rats.
• Antioxidant / endothelial (in vitro): Typhaneoside and I3ON promoted cell proliferation at concentrations of 2.8 to 70 μmol/L.
• Rhizome decoction (traditional, Ayurvedic context): Preparations described in some traditional sources involve boiling 10–15 g of dried rhizome in 500 mL water until reduced to approximately 200 mL.
• TCM traditional dosage forms: In TCM practice, Pu Huang is incorporated into oral decoctions and patent granule formulations, typically as part of multi-herb formulas such as Shi Xiao San. Formulations are utilized in treating conditions such as soft tissue contusion, functional uterine bleeding, chronic atrophic gastritis, and fundus vascular diseases.

No verified human clinical dosage ranges have been established in indexed peer-reviewed literature for any specific therapeutic indication. All dosages above derive from preclinical studies or traditional practice, and are cited only as reported in the referenced sources.

8. Safety Considerations and Interactions

General Toxicity

Acute oral toxicity studies of several Typha species and preparations have generally shown low acute toxicity at high doses. Extracts of T. domingensis were found safe and biocompatible at 3,000 mg/kg in rats. Similarly, administration of methanolic and ethyl acetate extracts of T. gallica at doses up to 3,000 mg/kg body weight in rats showed no acute toxicity symptoms. In an acute oral toxicity study of T. angustifolia pollen extracts, no deaths were observed at the doses tested.

Pregnancy

Uterine stimulation is a documented pharmacological property of cattail pollen that carries clinical significance for pregnant women. Traditional Chinese medicine literature records that T. angustifolia has the ability to induce uterine contractions. Typhae Pollen (Typha angustifolia, Pu Huang) was recorded in an analysis of Chinese herbal medicines with mouse fetal death under oral administration of a 10–21 g/kg decoction in animal studies. Pú Huáng is therefore contraindicated in pregnancy because of uterine stimulation.

Processing and Form-Specific Considerations

The raw form should be used cautiously in heavy bleeding without stasis; the charred form is appropriate when hemostasis is the priority. The differing phytochemical profiles of raw vs. charred pollen mean these preparations should not be regarded as interchangeable.

Drug Interactions

Given the established antiplatelet and anti-coagulant activities of certain compounds in Pollen Typhae (raw form), there is a theoretical basis for interaction with anticoagulant or antiplatelet drugs (e.g., warfarin, aspirin, clopidogrel). Some sources suggest Pu Huang may have mild hypotensive effects through its vascular actions; caution is warranted when combining with antihypertensive drugs, though clinical evidence is limited. These interactions have not been characterized in rigorous human pharmacokinetic interaction studies.

Heavy Metal Accumulation Risk

A notable, source-backed safety concern specific to Typha as a food or medicinal source is its phytoremediation capacity. The phytoremediation properties of T. angustifolia are due to its capacity to store and tolerate high concentrations of various metals. Because cattail plants accumulate heavy metals from polluted aquatic environments, plant material sourced from contaminated wetlands may carry elevated concentrations of lead, arsenic, cadmium, or other toxic metals. This is a practical safety concern relevant to wildcrafted or unregulated sourced preparations.

Herb–Drug Interaction Classification (TCM)

Pú Huáng is not listed in either of the two classical TCM incompatibility texts — Shi Ba Fan (Eighteen Antagonisms) or Shi Jiu Wei (Nineteen Mutual Inhibitions). This means it does not carry formal contraindications under traditional herbal compatibility frameworks, though this does not preclude interactions with pharmaceutical drugs.

Current Evidence Gaps and Research Needs

As summarized by the 2025 systematic review in Frontiers in Pharmacology, a variety of emerging technologies are being applied to quality control research of T. angustifolia. In order to establish a scientific and sound quality evaluation system, in-depth analysis of chemical information and pharmacodynamic results is still needed, along with identification of chemical substances with high correlation with pharmacological activity, to ensure the safety and effectiveness of clinical use.

In summary, the overwhelming body of evidence for Typha preparations in most therapeutic areas remains at the level of in vitro cell studies and animal models. Over 94 compounds have been isolated and identified from T. angustifolia, demonstrating significant pharmacological activities in preclinical settings such as anti-inflammatory, analgesic, anti-platelet aggregation, anti-atherosclerosis, and anti-oxidation; T. angustifolia is extensively utilized in modern clinical practice in treating dysmenorrhea, irregular menstruation, trauma bleeding, soft tissue contusion, hematochezia, hematuria, and abnormal uterine bleeding. Typha angustifolia has a wide range of biological activities, making it a valuable resource for discovering potential drug candidates and developing new botanical supplements. Prospective, blinded, randomized clinical trials in human populations are largely lacking, and such studies are needed to establish efficacy and safety for specific clinical indications.

References

• Liu J, et al. "Traditional uses and emerging therapeutic potential of Typha angustifolia L.: insights into its phytochemistry, pharmacological activities and quality control." Frontiers in Pharmacology, 2025. PMC12023270.
• Varpe SS, et al. "Evaluation of anti-inflammatory activity of Typha angustifolia pollen grains extracts in experimental animals." PMC3523511. J Pharmacognosy and Phytotherapy, 2012.
• Antioxidant capacity of Typha angustifolia extracts and two active flavonoids. PMC7011981.
• Gescher K, Deters AM. "Typha latifolia L. fruit polysaccharides induce the differentiation and stimulate the proliferation of human keratinocytes in vitro." J Ethnopharmacol, 2011. PMID: 21669276.
• Zhao J, et al. "The antiatherogenic effects of components isolated from pollen typhae." Thrombosis Research, 1990. PMID: 2116685.
• Fruet AC, et al. "Dietary intervention with narrow-leaved cattail rhizome flour (Typha angustifolia L.) prevents intestinal inflammation in the trinitrobenzenesulphonic acid model of rat colitis." BMC Complementary and Alternative Medicine, 2012. PMC3505175.
• Chemical Composition and Biological Evaluation of Typha domingensis Pers. to Ameliorate Health Pathologies: In Vitro and In Silico Approaches. PMC9303136.
• Chinese Medicinal Herb-Derived Carbon Dots for Common Diseases: Efficacies and Potential Mechanisms. PMC8906921.
• ScienceDirect Topics: Typha — overview of pharmacological and phytochemical properties.
• ScienceDirect Topics: Typha latifolia — overview.
• Pharmacological Potential and Electrochemical Characteristics of Typha angustifolia Pollen. PMC11511223.
• USDA NRCS Plant Guide: Southern Cattail (Typha domingensis).
• Texas Beyond History: Cattail ethnobotany and Native American uses.
• Overview of Contraindicated Chinese Medicines for Pregnancy. IntechOpen, 2017.
• Pu Huang (Typha Pollen): Benefits and Uses — TCM Materia Medica reference.
• Evaluation of anti-inflammatory activity of Typha angustifolia pollen grains extracts in experimental animals. PubMed PMID: 23248413.
• NC Native Ethnobotany Project: Cattails — Indigenous uses in North Carolina.